Skip to Main Content

Mark A Lemmon, PhD, FRS

David A. Sackler Professor of Pharmacology; Associate Cancer Center Director, Basic Science; Co-director, Cancer Biology Institute

Contact Information

Mark A Lemmon, PhD, FRS

Office Locations

Mailing Address

  • Pharmacology

    Department of Pharmacology, Yale School of Medicine, B326A Sterling Hall of Medicine

    New Haven, CT 06520-8066

    United States



Mark Lemmon, PhD was appointed the Co-Director of the Cancer Biology Institute and the David A. Sackler Professor of Pharmacology in 2015. Dr. Lemmon returns to Yale, where he completed his PhD in 1993, from the University of Pennsylvania’s Perelman School of Medicine. At UPenn, he was the George W. Raiziss Professor of Biochemistry and Biophysics as well as Chair of the department and an Investigator at the Abramson Family Cancer Research Institute. Dr. Lemmon’s research focuses on understanding the signaling networks controlled by receptor tyrosine kinase (RTK) growth factors that, when mutated, cause cancers and other diseases. His laboratory combines biochemical, structural, biophysical, and cellular approaches to investigate these networks, collaborating with clinical groups to apply the mechanistic lessons learned to inhibitor choice and combating development of resistance to targeted therapies in the clinic.

Education & Training

  • PhD
    Yale University (1993)
  • BA
    Oxford University (Hertford College), Biochemistry (1988)

Departments & Organizations